◆ 会议时间：2023年12月1-3日
◆ 会议地点：中国 台湾-台北
◆ 会议简介：
2023年第8届亚洲妇科肿瘤学会两年一次会议将于2023年12月1-3日在中国台北举行，来自亚洲和世界各地的杰出演讲者将发表演讲，主题涵盖各个领域，以讨论妇科肿瘤治疗和护理的最新进展。
亚洲妇科肿瘤学会(ASGO)成立于2008年，是亚洲致力于妇科肿瘤的研究、预防和治疗的重要学术组织。ASGO在亚洲十几个国家拥有会员，成员都是经过ASGO委员会认证的妇科肿瘤专家，在女性生殖道(卵巢、子宫内膜、子宫颈、外阴和阴道)恶性肿瘤的研究和治疗方面接受过强化的医学培训。ASGO成员为患有生殖道癌症的妇女提供从诊断到治疗的统一、全面的医疗和外科护理。未经本站许可禁止复制转载摘录镜像本站任何内容-领域国际医学会议网(lingyuint.com)。
ASGO 2023 -
8th Biennial Meeting of the Asia Society of Gynecologic Oncology (ASGO)
Date: 1-3 December, 2023
Venue: Taipei, Taiwan, China
摘要征文投稿：
Submission Period
- From now to August 30 (Wed.) UTC+8
点此提交摘要>>>Submit Abstract>>>
General Guidelines for Submission
- Abstracts must be original and must not be or have been published or presented at any other meeting prior to the 8th Biennial Meeting of Asian Society of Gynecologic Oncology (ASGO 2023).
- Abstracts must be submitted via our online Abstract Submission website after online registration. Please indicate whether the abstract is for Oral, Poster or Surgical Video Presentation.
- Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
- The Scientific Committee of ASGO 2023 will determine whether the abstract is accepted as an oral presentation or a poster presentation, with consideration given to the author’s preference.
- For any further information related to abstract submission, please contact Secretariat by e-mail (2023asgo@gmail.com).
- Ethical considerations: For clinical trials, details of ethical committee approval and types of informed consent should be stated. Names and initials of patients or volunteers should not be used.
- All presenters are required to register for the meeting and pay all applicable fees PRIOR to inclusion in the Final Program. This can be accomplished either prior or after the announcement of result. If you have paid the fees prior to the announcement but your abstract is not accepted by the Scientific Organizing Committee, you could apply for cancellation of registration via email(2023asgo@gmail.com).
Abstracts Format
- Capitalize the first letter of all words in your title. However, do not capitalize article words such as “a,” “the,” “and,” & “of” unless the article is the first word of the title.
- All abstracts must contain the following information: Introduction, Materials & Methods, Results and Conclusion.
- Abstracts should be no more than 400 words. Tables or figures are not allowed.
- All abstracts must be submitted and presented in English.
Abstract Acceptance
- The Scientific Committee of ASGO 2023 reserves the right to make the final decision of presentation categories and acceptance/rejection of abstract.
- Authors will be notified by email no later than September 15th, 2023 whether their abstract has been accepted or rejected.
- Submission of an abstract acknowledges your acceptance for the abstract to be published in the official congress book or any other meeting-related platform.
Presentation Time
- Oral presentations: 7-min each, followed by a discussion after every 3-4 presenters.
- Poster presentations: Poster size is W90xH120cm, please print and bring your own poster.
- Surgical video presentations: 7-min well edited video with a title page and narratives.
- Further information on the presentations will be notified by emails.
Personal Information
- Please note that registered personal information will not be used for purposes other than for the management and preparations for ASGO 2023. Accepted personal information will also be controlled with necessary security measures.
Submission Topics
- Cervical Cancer
- Endometrial Cancer
- Ovarian Cancer
- Vaginal and Vulvar Cancer
- Trophoblastic Diseases
- Other rare gynecological cancers
- Palliative Care & Quality of Life after Treatment of Gynecologic Cancer
- Non-invasive diseaseof Gynecologic Cancer (pre-cancer)
- Translational Research, Basic science& Novel therapy (ADC, cell therapy...)
- Surgical techniques (minimally invasive surgery, new method, HIPEC...)
- Immunotherapy and relevant topics
- Genomic,biomarker or prognostic marker
- Artificial intelligence(AI), database
- Imaging
Confident in the success of the ASGO Taipei 2023 meeting
How are you, colleagues? I’m Jae-Weon Kim, ASGO President for the year 2022-2023.
The COVID-19 pandemic, which began in 2020 and lasted for almost three years, is finally ending this year, and the previous conference structure has been fully reinstated. Of course, the most common format for meetings now is a hybrid one that includes both online and in-person components. The ASGO Taipei 2023 meeting will be adaptable and mindful of the demands of the area. The Taipei meeting will be the 15th ASGO gathering since its foundation. Beginning with its inaugural meeting in 2008 and its first Biennial meeting in Tokyo at the end of 2009, ASGO has hosted regular meetings every two years. In the intervening years, we organized a workshop on gynecologic oncology.
Recently we have seen unprecedented progress in our field. For example, it has recently been demonstrated that PARPi first-line maintenance therapy increases overall survival in epithelial ovarian cancers, and several medicines, including ADCs, are currently being studied in this field. The recent addition of pembrolizumab to cytotoxic drugs after bevacizumab was first added to treat recurrent cervical cancer has led to a median overall survival of over two years. The effectiveness of numerous immuno-oncology drugs has created new therapeutic possibilities for endometrial cancer.
ASGO is one of the well-known international societies in the arena of gynecologic cancer. By the way, ESMO Asia, ASCO Breakthrough, and other relevant meetings are competing in the field in addition to SGO, ESGO, and IGCS, and ESMO has formed a distinct gynecologic cancer conference demonstrates how hot the topic of gynecologic cancer has recently become. How can ASGO survive in an atmosphere of this kind of intense competition? It's a challenge for all of us.
Reflecting on these trends, this year’s Taipei meeting will cover high-income nations' problems and LMIC countries' fundamental challenges. The Radiotherapy Group, Cancer Registry, JGO, and Clinical trial groups will all have sessions. Moreover, the Special Task Force (STF)-Personalized Medicine, STF-Fertility Preservation, Education Committee, and Guideline Committee will be able to summarize their work and present their conclusions for 2022~2023 during this year's Taipei meeting. I thank the TAGO (Organizing Committee) members for their tireless efforts in planning such a challenging event.
The ASGO meeting will change from the Bali meeting in 2024 to an annual one. It is critical that the ASGO Taipei 2023 meeting be a success as we move toward this transition, and with the help of our members' active involvement - both in terms of abstract submissions and registration - let's solidify ASGO's status as a venue for debating topics specific to the Asian region. Show off our collective strength and power!
Thank you so much.
Jae-Weon Kim
ASGO President
注册费：
Registration Fees
Category |
Early Registration
(~ 2023. 10. 31) |
Pre-Registration
(2023. 11. 1 ~ 11. 15) |
On-Site Registration
(2023. 12. 01 ~ 12. 03) |
•Gynecology Oncologists
•Other Department Physician
•Employ of the Pharmaceutical Company |
400USD |
450USD |
500USD |
Fellow/Trainee |
300USD |
350USD |
400USD |
Resident/Researcher/Student |
200USD |
250USD |
300USD |
Accompanying Person
[Banquet only (12.02/ 12.03)] |
100USD |
100USD |
100USD |
※ All cut-off date are based on the local time (Taiwan, GMT+8).
1.Please be noted that registration fee must be paid in New Taiwan Doller (NT$) by credit card only.
2.To be able to qualify the registration rate of nurse or student, ID or relative identification must be uploaded for approval when signing up. |
Entitlements
Participants
- Conference program book and related information
- Admission to all scientific sessions of the Meeting
- Access to Exhibition Booths
- Lunches and coffee break during the Meeting
- Welcome Dinner
- Gala Dinner
How to Register
- For those who have not registered, please use a valid E-mail address to register at the online system. A confirmation letter will be emailed to you after completing a registration form. It is advisable to check all items listed.
- For Poster applicants, please login with the original registered account and password.
- After logging in, please complete the registration form. A confirmation letter will be emailed to you after completing the registration.
- Any changes or alterations can be made in writing by email to the ASGO 2023 Registration Office (2023asgo@gmail.com).
*Note: An e-mail account can only register once. The email account is important for confirmation and communications. Please be sure to fill in correctly.
Visa and Invitation Letter
Upon request, the system will automatically email a letter of invitation to facilitate a participant’s travel and visa arrangements. It does not imply provision of any financial or other support.
Cancellation & Refund Policy
Cancellation and refund must be sent in writing with the application form via email (2023asgo@gmail.com) to the Conference Secretariat. Verbal notification will not be accepted
The following rules of refunds will apply from the date of receipt of notification:
Cancellation received on or before November 5th, 2023: 70% refund.
After November 5th, 2023: No refund will be issued for cancellations or for no-shows.
Notes:
- All refund will be processed after the conference is concluded. Except for force majeure factors, late applications will not be refunded.
- Please note that all refunds will be made in TWD at the prevailing foreign exchange rate. Handling fee and bank charges shall be bore by the participants.
- Registrants who do not cancel by the above date and do not attend will be responsible for the full registration fee.
- Registrants are responsible for canceling their own hotel reservations. If the event is cancelled, the organization is not responsible for airfare, hotel or other costs incurred by the registrant.
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
